Decreased relative lymphocyte count in peripheral blood might reflect severe immune-related adverse events in melanoma patients treated with nivolumab

Explore related products in the following collection:

Poster Abstracts - C717

Related Products

Thumbnail for Characterization of SB 11285 as a novel STING agonist for Immuno-oncology

Characterization of SB 11285 as a novel STING agonist for Immuno-oncology

Thumbnail for Targeted NK cells display potent activity against glioblastoma and induce protective antitumor immunity

Targeted NK cells display potent activity against glioblastoma and induce protective antitumor immunity

Thumbnail for Blocking LILRB signaling impedes cancer development and targets immune checkpoints

Blocking LILRB signaling impedes cancer development and targets immune checkpoints

Thumbnail for Modulating the tumor microenvironment to induce cross priming for cancer immunotherapy

Modulating the tumor microenvironment to induce cross priming for cancer immunotherapy

Privacy Policy Update: We value your privacy and want you to understand how your information is being used. To make sure you have current and accurate information about this sites privacy practices please visit the privacy center by clicking here.